ChimeriVax: Clinical Trials

2 completed. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2

Follow ChimeriVax: new trials by email Literature Review of ChimeriVax trials Research Report on ChimeriVax

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects CYD dengue vaccine serotypes (1, 2, 3, 4)., Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide - Dengue Virus, Dengue Fever	Phase 2	Completed	Sanofi Pasteur, a Sanofi Company	180	2009-03-01	2022-04-05
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years CYD Dengue Vaccine Serotypes 1, 2, 3, and 4, Pneumococcal polysaccharide vaccine - Dengue Virus, Dengue Fever	Phase 2	Completed	Sanofi Pasteur, a Sanofi Company	300	2008-09-26	2022-04-05

Conditions studied

Dengue (2)  ·  Severe Dengue (2)

Sponsors

Sanofi Pasteur, a Sanofi Company (2)

Countries

Peru (1)  ·  Vietnam (1)

Results publications

PMID 22863660

NIH funding

2014 (2)